Issue 23, 2013

UPLC-MS/MS determination and pharmacokinetic study of 26-OH-panaxadiol in rat plasma

Abstract

Dammar-20S, 25R-epoxy-3β, 12β, 26-triol (26-OH-panaxadiol), the new sapogenin product of the oxidative cyclization of protopanaxadiol from ginseng, exhibits a significant pharmacological effect as an anti-tumor agent. A sensitive and rapid analytical method based on ultra-performance liquid chromatography coupled with tandem mass spectrometry (UPLC-MS/MS) was initially developed for the detection of 26-OH-panaxadiol in rat plasma. Pre-treatment of the sample obtained from the plasma involved a single protein precipitation step using methanol. 26-OH-panaxadiol and an internal standard (IS), tanshinone II A, were separated on a Waters ACQUITY UPLC BEH C18 analytical column (50 mm × 2.1 mm, 1.7 μm) using acetonitrile–0.1% formic acid in water (80 : 20, v/v) as the mobile phase, at a flow rate of 0.3 mL min−1. Chromatography of the 26-OH-panaxadiol and IS was performed within 3 minutes. Detection was performed through positive ion electrospray ionization (ESI+) in multiple reaction monitoring (MRM) mode. The assay was linear over the concentration range of 1–1000 ng mL−1 (r > 0.9960). The limit of detection (LOD) and the lower limit of quantification (LLOQ) were 0.3 ng mL−1 and 1.0 ng mL−1, respectively. The intra- and inter-day deviations (expressed as relative standard deviation, RSD) were ≤4.8% and ≤8.5%, respectively, and the accuracy (expressed as relative error, RE) was in the range of 4.5% to 5.3%. The recoveries of 26-OH-panaxadiol and IS were 91.2% and 98.7%, respectively, and the matrix effects were satisfactory in all of the biological matrices examined. This fully validated method was successfully applied to the pharmacokinetic study of rats after a single initial intragastric administration of 15 mg kg−1 26-OH-panaxadiol. The main pharmaco-kinetic parameters: Tmax (the time to peak), Cmax (the concentration to peak), and t1/2 (the biological half life) were 3.08 ± 1.24 h, 2833.86 ± 1246.08 μg L−1, 5.14 ± 1.01 h, respectively.

Graphical abstract: UPLC-MS/MS determination and pharmacokinetic study of 26-OH-panaxadiol in rat plasma

Article information

Article type
Paper
Submitted
02 Aug 2013
Accepted
20 Sep 2013
First published
20 Sep 2013

Anal. Methods, 2013,5, 6656-6662

UPLC-MS/MS determination and pharmacokinetic study of 26-OH-panaxadiol in rat plasma

M. Lin, H. Gao, J. Liu, L. Han, Q. Zhang and P. Li, Anal. Methods, 2013, 5, 6656 DOI: 10.1039/C3AY41320A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements